These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 16163229

  • 1. New strategies for MGUS and smoldering multiple myeloma.
    Kyle RA.
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):507, 509. PubMed ID: 16163229
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
    Chiu W, Pullon H, Woon ST, Oei P, The R, Ameratunga R.
    Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486
    [No Abstract] [Full Text] [Related]

  • 4. Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.
    Anagnostopoulos A, Galani E, Gika D, Sotou D, Evangelopoulou A, Dimopoulos MA.
    Ann Hematol; 2004 Oct; 83(10):658-60. PubMed ID: 15278296
    [Abstract] [Full Text] [Related]

  • 5. [Progress in the management of multiple myeloma introduced by serum free light chain measurement].
    Fuchida S, Shimazaki C.
    Nihon Rinsho; 2011 Dec; 69(12):2267-73. PubMed ID: 22242331
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
    Wolff F, Thiry C, Willems D.
    Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
    [Abstract] [Full Text] [Related]

  • 8. Circulating monotypic B-cells in multiple myeloma: association with lambda paraproteins.
    Bagg A, Becker P, Bezwoda W, van Rensburg L, Mendelow B.
    Br J Haematol; 1989 Jun; 72(2):167-72. PubMed ID: 2503024
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study].
    Le Moigne M, Mazereeuw-Hautier J, Bonnetblanc JM, Astudillo L, D'Incan M, Bessis D, Thomas L, Debarbieux S, Ammoury A, Lamant L, Paul C.
    Ann Dermatol Venereol; 2010 Dec; 137(12):782-8. PubMed ID: 21134580
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].
    Buiting AM, Wijermans PW.
    Ned Tijdschr Geneeskd; 2002 Jul 27; 146(30):1406-11. PubMed ID: 12174434
    [Abstract] [Full Text] [Related]

  • 13. Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression.
    Gran C, Luong V, Bruchfeld JB, Liwing J, Afram G, Lund J, Usmani S, Alici E, Nahi H.
    Am J Hematol; 2021 Mar 01; 96(3):E63-E65. PubMed ID: 33264449
    [No Abstract] [Full Text] [Related]

  • 14. The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.
    Caers J, Fernández de Larrea C, Leleu X, Heusschen R, Zojer N, Decaux O, Kastritis E, Minnema M, Jurczyszyn A, Beguin Y, Wäsch R, Palumbo A, Dimopoulos M, Mateos MV, Ludwig H, Engelhardt M.
    Oncologist; 2016 Mar 01; 21(3):333-42. PubMed ID: 26921288
    [Abstract] [Full Text] [Related]

  • 15. Comparison of free κ and λ light chain immunoassays and total (bound and free) κ and λ light chain immunoassays.
    Delgado F, Kuus K.
    Rev Invest Clin; 2014 Mar 01; 66(5):473-4. PubMed ID: 25695391
    [No Abstract] [Full Text] [Related]

  • 16. [Monoclonal gammapathy of undetermined significance and autoimmune disease: description of three cases in Senegal].
    Diallo S, Ndiaye FS, Pouye A, Lèye A, Touré MA, Diop S, Dièye T, Ka MM, Thiam D, Diakhaté L, Diop TM.
    Med Trop (Mars); 2008 Feb 01; 68(1):65-8. PubMed ID: 18478776
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic significance of kappa/lambda and lambda/kappa ratio in paraproteinemias.
    Tichý M, Hrncír Z.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982 Feb 01; 25(3-4):313-8. PubMed ID: 6820852
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A Rapidly Deteriorating Patient with Gross Increase in Serum Free Light Chains.
    Fung AWS, Kohlhagen MC, DeMarco ML, Mills JR.
    Clin Chem; 2019 Sep 01; 65(9):1084-1088. PubMed ID: 31481352
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.